$2.62 Billion is the total value of Cormorant Asset Management, LP's 81 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 27.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $176,802,000 | +29.5% | 2,737,297 | -10.5% | 6.75% | +6.4% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $154,180,000 | -40.2% | 500,000 | -50.0% | 5.88% | -50.9% |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $152,547,000 | – | 3,379,373 | +100.0% | 5.82% | – |
| CCXI | Sell | CHEMOCENTRYX INC | $97,818,000 | +20.2% | 1,700,000 | -16.0% | 3.73% | -1.3% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $95,096,000 | -23.7% | 1,590,493 | -24.3% | 3.63% | -37.4% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $84,485,000 | -1.2% | 2,590,762 | -12.2% | 3.22% | -18.9% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $82,737,000 | +36.5% | 2,636,661 | -4.7% | 3.16% | +12.1% |
| IWM | New | ISHARES TRput | $71,590,000 | – | 500,000 | +100.0% | 2.73% | – |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $68,026,000 | +50.5% | 1,574,683 | -9.1% | 2.60% | +23.6% |
| RNA | New | AVIDITY BIOSCIENCES INC | $67,804,000 | – | 2,514,547 | +100.0% | 2.59% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $67,479,000 | +11.2% | 2,066,108 | -8.8% | 2.58% | -8.7% |
| VIE | Sell | VIELA BIO INC | $65,522,000 | -2.2% | 1,512,500 | -14.2% | 2.50% | -19.7% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $62,408,000 | -11.3% | 400,000 | -17.9% | 2.38% | -27.1% |
| MYOK | Sell | MYOKARDIA INC | $57,972,000 | +76.7% | 600,000 | -14.3% | 2.21% | +45.0% |
| CCXI | Buy | CHEMOCENTRYX INCcall | $57,540,000 | +129.1% | 1,000,000 | +60.0% | 2.20% | +88.1% |
| XLRN | Sell | ACCELERON PHARMA INC | $57,162,000 | -22.9% | 600,000 | -27.3% | 2.18% | -36.7% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $57,085,000 | -12.6% | 500,000 | -41.2% | 2.18% | -28.3% |
| XBI | New | SPDR SER TRput | $55,975,000 | – | 500,000 | +100.0% | 2.14% | – |
| MYOV | Sell | MYOVANT SCIENCES LTD | $51,550,000 | +162.6% | 2,500,000 | -3.8% | 1.97% | +115.7% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $50,306,000 | -6.6% | 1,055,302 | -4.1% | 1.92% | -23.4% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $43,866,000 | +47.2% | 600,000 | -31.5% | 1.67% | +21.0% |
| AGEN | Sell | AGENUS INC | $43,230,000 | +44.9% | 11,000,000 | -9.6% | 1.65% | +19.0% |
| OMER | Buy | OMEROS CORP | $40,848,000 | +21.1% | 2,775,000 | +10.0% | 1.56% | -0.6% |
| SRNE | Buy | SORRENTO THERAPEUTICS INC | $40,820,000 | +343.7% | 6,500,000 | +30.0% | 1.56% | +264.9% |
| STOK | Sell | STOKE THERAPEUTICS INC | $40,542,000 | +3.5% | 1,701,292 | -0.5% | 1.55% | -15.0% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDG I | $37,392,000 | +950.0% | 800,000 | +205.3% | 1.43% | +764.8% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $30,737,000 | +40.5% | 1,468,550 | -6.4% | 1.17% | +15.3% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $29,396,000 | +10.0% | 400,000 | -36.5% | 1.12% | -9.7% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $28,798,000 | -2.1% | 350,000 | -30.0% | 1.10% | -19.6% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $27,300,000 | +3.7% | 350,000 | -22.2% | 1.04% | -14.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $25,883,000 | -8.1% | 175,000 | -30.0% | 0.99% | -24.5% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $25,293,000 | +24.4% | 720,397 | -10.0% | 0.96% | +2.1% |
| TWST | Sell | TWIST BIOSCIENCE CORP | $25,044,000 | +19.2% | 552,849 | -19.5% | 0.96% | -2.0% |
| IGMS | Sell | IGM BIOSCIENCES INC | $24,831,000 | +3.8% | 340,146 | -20.2% | 0.95% | -14.8% |
| TCDA | Sell | TRICIDA INC | $23,966,000 | +24.1% | 872,137 | -0.7% | 0.91% | +1.9% |
| CABA | Sell | CABALETTA BIO INC | $23,459,000 | +52.6% | 2,105,844 | -0.0% | 0.90% | +25.4% |
| STSA | Sell | SATSUMA PHARMACEUTICALS INC | $22,977,000 | +32.1% | 798,905 | -1.2% | 0.88% | +8.5% |
| BEAM | BEAM THERAPEUTICS INC | $22,036,000 | +53.7% | 796,429 | 0.0% | 0.84% | +26.3% | |
| QTNT | Sell | QUOTIENT LTD | $21,463,000 | +71.9% | 2,900,399 | -8.3% | 0.82% | +41.2% |
| ZLAB | Sell | ZAI LAB LTDadr | $20,533,000 | +38.0% | 250,000 | -13.5% | 0.78% | +13.3% |
| QURE | Buy | UNIQURE NV | $20,014,000 | +68.7% | 444,157 | +77.7% | 0.76% | +38.7% |
| ZYME | Sell | ZYMEWORKS INC | $19,839,000 | -20.1% | 550,000 | -21.4% | 0.76% | -34.4% |
| ANAB | Sell | ANAPTYSBIO INC | $19,790,000 | +26.4% | 885,838 | -20.0% | 0.76% | +3.9% |
| GLPG | Buy | GALAPAGOS NVspon adr | $19,484,000 | -1.0% | 99,075 | +0.5% | 0.74% | -18.7% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $19,046,000 | +32.2% | 318,914 | -8.9% | 0.73% | +8.5% |
| PLRX | New | PLIANT THERAPEUTICS, INC | $18,812,000 | – | 611,409 | +100.0% | 0.72% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $17,637,000 | +20.2% | 110,000 | -26.7% | 0.67% | -1.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $15,766,000 | +49.6% | 70,000 | -12.5% | 0.60% | +22.9% |
| NXTC | Sell | NEXTCURE INC | $14,879,000 | -46.0% | 693,971 | -6.6% | 0.57% | -55.6% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $14,766,000 | +8.4% | 592,539 | -7.8% | 0.56% | -11.1% |
| ALLK | Sell | ALLAKOS INC | $14,193,000 | +59.5% | 197,515 | -1.2% | 0.54% | +31.2% |
| INSP | Sell | INSPIRE MED SYS INC | $12,877,000 | +42.4% | 147,982 | -1.3% | 0.49% | +16.9% |
| INSM | Buy | INSMED INC | $12,393,000 | +113.4% | 450,000 | +24.2% | 0.47% | +75.2% |
| BNTX | New | BIONTECH SEsponsored ads | $11,680,000 | – | 175,000 | +100.0% | 0.45% | – |
| KURA | Sell | KURA ONCOLOGY INC | $11,410,000 | +43.3% | 700,000 | -12.5% | 0.44% | +17.6% |
| RPTX | New | REPARE THERAPEUTICS INC | $10,944,000 | – | 352,795 | +100.0% | 0.42% | – |
| HARP | Sell | HARPOON THERAPEUTICS INC | $10,711,000 | +42.3% | 645,257 | -0.7% | 0.41% | +16.9% |
| AKUS | New | AKOUOS INC | $10,670,000 | – | 499,990 | +100.0% | 0.41% | – |
| MRUS | MERUS N V | $9,654,000 | +33.0% | 600,000 | 0.0% | 0.37% | +9.2% | |
| KDMN | New | KADMON HLDGS INC | $9,216,000 | – | 1,800,000 | +100.0% | 0.35% | – |
| FIXX | Sell | HOMOLOGY MEDICINES INC | $8,355,000 | -10.4% | 550,000 | -8.3% | 0.32% | -26.3% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $7,694,000 | +167.6% | 479,988 | 0.0% | 0.29% | +119.4% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $6,953,000 | – | 1,350,000 | +100.0% | 0.26% | – |
| BCEL | Sell | ATRECA INC | $6,838,000 | +26.7% | 321,322 | -1.5% | 0.26% | +4.0% |
| BNR | New | BURNING ROCK BIOTECH LTDsponsored ads | $6,753,000 | – | 250,000 | +100.0% | 0.26% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $6,734,000 | – | 1,300,000 | +100.0% | 0.26% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $6,720,000 | +21.2% | 700,000 | -14.1% | 0.26% | -0.8% |
| GTH | New | GENETRON HLDGS LTDads | $6,035,000 | – | 500,000 | +100.0% | 0.23% | – |
| AVRO | AVROBIO INC | $5,542,000 | +12.1% | 317,579 | 0.0% | 0.21% | -8.3% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,721,000 | +12.4% | 75,000 | -25.0% | 0.18% | -7.7% |
| ARYBU | New | ARYA SCIENCES ACQUISITION COunit 06/09/2027 | $4,640,000 | – | 400,000 | +100.0% | 0.18% | – |
| GOSS | Buy | GOSSAMER BIO INC | $4,541,000 | +125.5% | 349,325 | +76.1% | 0.17% | +84.0% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $4,152,000 | +15.3% | 600,000 | -33.3% | 0.16% | -5.4% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $2,895,000 | +8.1% | 125,000 | -16.7% | 0.11% | -11.3% |
| DTIL | PRECISION BIOSCIENCES INC | $2,887,000 | +38.1% | 346,524 | 0.0% | 0.11% | +13.4% | |
| TBPH | THERAVANCE BIOPHARMA INC | $2,099,000 | -9.2% | 100,000 | 0.0% | 0.08% | -25.2% | |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $1,849,000 | -49.5% | 512,159 | -15.7% | 0.07% | -58.2% |
| XFOR | Sell | X4 PHARMACEUTICALS INC -CW24 | $1,757,000 | -48.6% | 328,980 | -3.7% | 0.07% | -57.9% |
| FATE | Sell | FATE THERAPEUTICS INC | $1,716,000 | +3.0% | 50,000 | -33.3% | 0.06% | -15.6% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,540,000 | -20.3% | 256,649 | 0.0% | 0.06% | -34.4% | |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $117,000 | +80.0% | 416,666 | 0.0% | 0.00% | +33.3% | |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -25,000 | -100.0% | -0.10% | – |
| IMVTU | Exit | IMMUNOVANT INCunit 12/18/2024 | $0 | – | -1,078,380 | -100.0% | -0.90% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcall | $0 | – | -250,000 | -100.0% | -1.68% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -1.79% | – |
| ASND | Exit | ASCENDIS PHARMA A Scall | $0 | – | -350,000 | -100.0% | -1.83% | – |
| CNST | Exit | CONSTELLATION PHARMACEUTICALS I | $0 | – | -2,040,021 | -100.0% | -2.98% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.